Awakn Life Sciences - Live Discussion

Awakn Life Sciences - Live Discussion

Wednesday, April 21, 2021 3:00 PM to 3:30 PM · 30 min. (Africa/Abidjan)
Roundtable will open Wednesday, April 21, 2021 3:00 PM
This roundtable has ended.

Information

Ask Awakn Life Sciences questions about their presentation, either in the chat stream or on camera. Connect with represenatives, discover the opportunities and network with like-minded attendees.  

Awakn Life SciencesAwakn Life Sciences is a clinical-biotech company researching, developing, and delivering  psychedelic New Molecular Entity drugs and therapies to treat Addiction. We are integrating psychedelic medicine into mainstream healthcare to enable better mental health for more people through Research, Digital, Clinics, and Ecosystems. We have a dual strategic focus, to develop and commercialise proprietary psychedelic therapies and New Molecular Entity drugs and to treat Addiction and other mental health conditions in a chain of medical psychedelic clinics across the UK and EU. Our goals are to be the global leader in the research of psychedelic therapies and New Molecular Entity drugs to treat Addiction, build the UK and EU’s leading chain of medical psychedelic clinics, and scale our reach through our Partnerships Ecosystem. 

Pharmaceuticals, Healthcare & Life Sciences

Anthony Tennyson
Anthony Tennyson
CEOAwakn

Registered attendees

Beriwan Ceren
Beriwan Ceren
ConsultantBeckley Waves
Caroline Haertel
Caroline Haertel
Journalist/Filmmakermicafilm
CL
Cecilia Lacombe
Production ManagerProhibition Partners

Log in